Trial Outcomes & Findings for Feasibility of iFS™ for Intrastromal Arcuate Keratotomy (ISAK) Procedures (NCT NCT01210820)

NCT ID: NCT01210820

Last Updated: 2013-05-01

Results Overview

Change in mean cylinder (assessed by manifest refraction) compared to baseline.

Recruitment status

COMPLETED

Study phase

NA

Target enrollment

21 participants

Primary outcome timeframe

6 months

Results posted on

2013-05-01

Participant Flow

Participants were recruited from an Ophthalmic medical clinic during the period of July 2010 to April 2011.

Participant milestones

Participant milestones
Measure
Natural Astigmatism
Subjects with refractive astigmatism and no prior history of ophthalmic surgery. May include subjects with cataracts. iFS™ Femtosecond Laser System : intrastromal arcuate cuts made with iFS™ femtosecond laser
Post Cataract With Residual Astigmatism
Subjects who have had cataract removal surgery but have residual astigmatism. iFS™ Femtosecond Laser System : intrastromal arcuate cuts made with iFS™ femtosecond laser
Overall Study
STARTED
17
4
Overall Study
COMPLETED
17
4
Overall Study
NOT COMPLETED
0
0

Reasons for withdrawal

Withdrawal data not reported

Baseline Characteristics

Feasibility of iFS™ for Intrastromal Arcuate Keratotomy (ISAK) Procedures

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
Natural Astigmatism
n=17 Participants
Subjects with refractive astigmatism and no prior history of ophthalmic surgery. May include subjects with cataracts. iFS Femtosecond Laser System : intrastromal arcuate cuts made with iFS femtosecond laser
Post Cataract With Residual Astigmatism
n=4 Participants
Subjects who have had cataract removal surgery but have residual astigmatism. iFS Femtosecond Laser System : intrastromal arcuate cuts made with iFS femtosecond laser
Total
n=21 Participants
Total of all reporting groups
Age Continuous
66 years
STANDARD_DEVIATION 12.4 • n=99 Participants
61 years
STANDARD_DEVIATION 12.1 • n=107 Participants
65 years
STANDARD_DEVIATION 12.2 • n=206 Participants
Sex: Female, Male
Female
7 Participants
n=99 Participants
3 Participants
n=107 Participants
10 Participants
n=206 Participants
Sex: Female, Male
Male
10 Participants
n=99 Participants
1 Participants
n=107 Participants
11 Participants
n=206 Participants
Region of Enrollment
Austria
17 participants
n=99 Participants
4 participants
n=107 Participants
21 participants
n=206 Participants

PRIMARY outcome

Timeframe: 6 months

Change in mean cylinder (assessed by manifest refraction) compared to baseline.

Outcome measures

Outcome measures
Measure
Natural Astigmatism
n=17 Participants
Subjects with refractive astigmatism and no prior history of ophthalmic surgery. May include subjects with cataracts. iFS Femtosecond Laser System : intrastromal arcuate cuts made with iFS femtosecond laser
Post Cataract With Residual Astigmatism
n=4 Participants
Subjects who have had cataract removal surgery but have residual astigmatism. iFS Femtosecond Laser System : intrastromal arcuate cuts made with iFS femtosecond laser
Change in Refractive Astigmatism
-0.97 Diopter of cylinder change
Standard Deviation 0.43
-0.81 Diopter of cylinder change
Standard Deviation 0.35

PRIMARY outcome

Timeframe: 6 Months

Change in mean keratometric cylinder (as measured by keratometry) compared to baseline.

Outcome measures

Outcome measures
Measure
Natural Astigmatism
n=17 Participants
Subjects with refractive astigmatism and no prior history of ophthalmic surgery. May include subjects with cataracts. iFS Femtosecond Laser System : intrastromal arcuate cuts made with iFS femtosecond laser
Post Cataract With Residual Astigmatism
n=4 Participants
Subjects who have had cataract removal surgery but have residual astigmatism. iFS Femtosecond Laser System : intrastromal arcuate cuts made with iFS femtosecond laser
Change in Keratometric Cylinder
-0.81 Diopters of astigmatism change
Standard Deviation 0.62
-0.63 Diopters of astigmatism change
Standard Deviation 0.78

Adverse Events

Natural Astigmatism

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Post Cataract With Residual Astigmatism

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Adverse event data not reported

Additional Information

Carrie Garufis

AMO Development, LLC

Phone: 714-566-3728

Results disclosure agreements

  • Principal investigator is a sponsor employee At least 1 month prior to any proposed submission for publication or presentation of Trial data or other findings related to the Trial, the Institution will provide the Sponsor with a manuscript for review, comment, and approval. Under no circumstances shall the Institution or PI publish or disclose the Sponsor's confidential Information without the Sponsor's prior written approval.The manner in which the publication will be generated will be negotiated between the Sponsor and PI.
  • Publication restrictions are in place

Restriction type: OTHER